Search
Drug Impact Events
| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 12/11/15 | BTG plc (BTC:LN) | Vistogard for Drug Toxicity | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/11/15 | Roche (RHHBF) | Alecensa for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/11/15 | Crealta | Krystexxa for Gout | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/11/15 | Takeda (4502:JP) | Ninlaro for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 12/11/15 | Eli Lilly (LLY) | BioChaperone Lispro U200 for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 12/12/15 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 12/12/15 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 12/12/15 | Subscribers Only | Subscribers Only | Trial Data - Final Results |
| 12/12/15 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 12/12/15 | Subscribers Only | Subscribers Only | Trial Data - Other |
